Dulaglutide,923950-08-7

Aliasulaglutide - mhinduro muPBS/ dulaglutide

Nhamba yeCAS:923950-08-7

Kambani Nhamba :GT-F002

Sequence: H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Glu-Gln-Ala-Ala-Lys-Glu-Phe-Ile- Ala-Trp-Leu-Val-Lys-Gly-Gl y-Gly-OH

Molecular formula: C149H221N37O49

Molecular uremu: 3314.62

Dulaglutide CAS NO.923950-08-7.jpg

Technical zviratidzo:

Kuonekwa White powder
Kuchena (HPLC) yaive ≥95.0%

Iyo imwechete heterozygosity yaive isingasviki 2.0%

Acetic acid yemukati yakabva pa5.0% kusvika 12.0%

Hunyoro hwemukati hwaive ≤10.0%

Peptide yemukati yaive ≥80.0%

Kurongedza uye Kutumira:

Kudzikira tembiricha, vacuum kurongedza, yakarurama kune milligram pakukumbira.

Product Description:

Durraglutide inyowani inobata GLP-1R agonist nyowani, inotorwa kubva mukusanganiswa kweaviri DPP-4 inhibitory GLP-1 analogues uye yemunhu immunoglobulin inorema cheni IgG4-Fc chidimbu.Basa rayo rakafanana neiyo endogenous GLP-1 mukuratidzwa kwekiriniki, ine hafu yehupenyu hwemazuva mashanu, uye inogona kunyatso kunonoka kubvumidzwa kwetsvo.Iyo FDA yakabvumira dulaglutide kuti ishandiswe jekiseni rezasi muna Gunyana 2014. European Commission yakatendera dulaglutide jekiseni repasi pecutaneous muEurope muna Zvita 2014.

Kuchengetedza: Kuomesa nechando pa -20 ℃ uye kuchengetwa kure nechiedza

Cherechedza: Nezvinangwa zvekutsvaga chete, kwete zvezvidzidzo zvevanhu